OpenURL Connection Search

Select item for more details and to access through your institution.

Quality by design enabled formulation development of regorafenib monohydrate loaded PEGylated PLGA polymeric nanoparticles: Enhanced oral bioavailability and biopharmaceutical attributes.
Published in:
Nanomedicine Journal, 2024, v. 11, n. 4, p. 401, doi. 10.22038/nmj.2024.76842.1867
By:
- Panigrahi, Dhananjay;
- Swain, Suryakanta;
- Sahu, Pratap Kumar;
- Ghose, Debashish;
- Jena, Bikash Ranjan
Publication type:
Article
Dual role of mesenchymal stem/stromal cells and their cell‐free extracellular vesicles in colorectal cancer.
Published in:
Cell Biochemistry & Function, 2024, v. 42, n. 2, p. 1, doi. 10.1002/cbf.3962
By:
- Saadh, Mohamed J.;
- Mohamed, Asma'a H.;
- Almoyad, Muhammad Ali Abdullah;
- Allela, Omer Qutaiba B.;
- Amin, Ali H.;
- Malquisto, April Ann;
- Jin, Wong Tze;
- Sârbu, Ioan;
- AlShamsi, Faisal;
- Elsaid, Fahmy Gad;
- Akhavan‐Sigari, Reza
Publication type:
Article
Heat shock protein 90 (HSP90) inhibitors in gastrointestinal cancer: where do we currently stand?—A systematic review.
Published in:
Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 8039, doi. 10.1007/s00432-023-04689-z
By:
- Magyar, Christian Tibor Josef;
- Vashist, Yogesh K.;
- Stroka, Deborah;
- Kim-Fuchs, Corina;
- Berger, Martin D.;
- Banz, Vanessa M.
Publication type:
Article
Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study.
Published in:
Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 4091, doi. 10.1007/s00432-022-04302-9
By:
- Xu, Chao;
- Xie, Xiaoli;
- Kang, Ning;
- Jiang, Huiqing
Publication type:
Article
The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy.
Published in:
Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2335, doi. 10.1007/s00432-022-04037-7
By:
- Li, Man Yi;
- Mi, Le;
- Meerovich, Gennady;
- Soe, Thin Wut;
- Chen, Ting;
- Than, Ni Ni;
- Yan, Yi Jia;
- Chen, Zhi Long
Publication type:
Article
The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors.
Published in:
Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2427, doi. 10.1007/s00432-021-03781-6
By:
- Kim, Hana;
- Ahn, Soomin;
- Kim, Hongsik;
- Hong, Jung Yong;
- Lee, Jeeyun;
- Park, Se Hoon;
- Park, Joon Oh;
- Park, Young Suk;
- Lim, Ho Yeong;
- Kang, Won Ki;
- Kim, Kyoung-Mee;
- Kim, Seung Tae
Publication type:
Article
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis.
Published in:
Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 12, p. 3665, doi. 10.1007/s00432-021-03602-w
By:
- Casadei-Gardini, Andrea;
- Rimassa, Lorenza;
- Rimini, Margherita;
- Yoo, Changhoon;
- Ryoo, Baek-Yeol;
- Lonardi, Sara;
- Masi, Gianluca;
- Kim, Hyung-Don;
- Vivaldi, Caterina;
- Ryu, Min-Hee;
- Rizzato, Mario Domenico;
- Salani, Francesca;
- Bang, Yeonghak;
- Pellino, Antonio;
- Catanese, Silvia;
- Burgio, Valentina;
- Cascinu, Stefano;
- Cucchetti, Alessandro
Publication type:
Article
Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens.
Published in:
Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 10, p. 2993, doi. 10.1007/s00432-021-03708-1
By:
- Cao, Fei;
- Zheng, Jiaping;
- Luo, Jun;
- Zhang, Zhewei;
- Shao, Guoliang
Publication type:
Article
Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system.
Published in:
Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 1, p. 263, doi. 10.1007/s00432-020-03335-2
By:
- Hirsch, Daniela;
- Gaiser, Timo;
- Merx, Kirsten;
- Weingaertner, Simone;
- Forster, Michael;
- Hendricks, Alexander;
- Woenckhaus, Matthias;
- Schubert, Thomas;
- Hofheinz, Ralf-Dieter;
- Gencer, Deniz
Publication type:
Article
Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12.
Published in:
2020
By:
- Park, Ji Hyun;
- Chun, Sang Hoon;
- Lee, Yun-Gyoo;
- Chang, Hyun;
- Lee, Keun-Wook;
- Kim, Hye Ryun;
- Shin, Seong Hoon;
- An, Ho Jung;
- Lee, Kyoung Eun;
- Hwang, In Gyu;
- Ahn, Myung-Ju;
- Kim, Sung-Bae;
- Keam, Bhumsuk
Publication type:
Correction Notice
Regorafenib in patients with recurrent high-grade astrocytoma.
Published in:
Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 4, p. 1037, doi. 10.1007/s00432-019-02868-5
By:
- Kebir, Sied;
- Rauschenbach, Laurel;
- Radbruch, Alexander;
- Lazaridis, Lazaros;
- Schmidt, Teresa;
- Stoppek, Ann-Kathrin;
- Pierscianek, Daniela;
- Stuschke, Martin;
- Forsting, Michael;
- Sure, Ulrich;
- Keyvani, Kathy;
- Kleinschnitz, Christoph;
- Scheffler, Björn;
- Glas, Martin
Publication type:
Article
Regorafenib inhibits growth, survival and angiogenesis in nasopharyngeal carcinoma and is synergistic with Mcl-1 inhibitor.
Published in:
Journal of Pharmacy & Pharmacology, 2023, v. 75, n. 9, p. 1177, doi. 10.1093/jpp/rgad034
By:
- Li, Jiangping;
- Hua, Qingquan
Publication type:
Article
Regorafenib Dose-Escalation Strategy Potentially a New Standard in Metastatic Colorectal Cancer.
Published in:
Oncology Practice Management, 2018, v. 8, n. 3, p. 1
By:
- Kuznar, Wayne
Publication type:
Article
Diabetes Mellitus Induced by Nivolumab plus Regorafenib in a Patient with Esophageal Cancer.
Published in:
Journal of Cancer Research & Practice, 2024, v. 11, n. 2, p. 81, doi. 10.4103/ejcrp.eJCRP-D-23-00025
By:
- Mei-Chen Lin;
- Li-Yuan Bai;
- Shih-Peng Yeh;
- Chang-Fang Chiu;
- Ming-Yu Lien
Publication type:
Article
Prognostic and monitoring value of tissue inhibitors of matrix metalloproteinases TIMP-1 and TIMP-2 in patients with colorectal cancer.
Published in:
Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2020, v. 66, n. 1, p. 3, doi. 10.33320/maced.pharm.bull.2020.66.01.003
By:
- Kostova, Elena;
- Stratrova, Slavica Shubeska
Publication type:
Article
Dramatic response to regorafenib in early glioblastoma progression: case report and review of the literature.
Published in:
European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 14, p. 5008
By:
- DE FELICE, M.;
- DE MARINIS, P.;
- MARTIN, G.;
- BRUSCELLA, S.;
- DE BELLIS, A.;
- POLIERO, L.;
- TURITTO, G.
Publication type:
Article
Corrigendum to "Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models".
Published in:
2019
By:
- Zhang, Qing;
- Zhang, Haixu;
- Ding, Jiage;
- Liu, Hongyan;
- Li, Huizhong;
- Li, Hailong;
- Lu, Mengmeng;
- Miao, Yangna;
- Li, Liantao;
- Zheng, Junnian
Publication type:
journal article
Comparison of the crystal structures of the potent anticancer and anti-angiogenic agent regorafenib and its monohydrate.
Published in:
Acta Crystallographica Section C: Structural Chemistry, 2016, v. 72, n. 4, p. 291, doi. 10.1107/S2053229616003727
By:
- Sun, Meng-Ying;
- Wu, Su-Xiang;
- Zhou, Xin-Bo;
- Gu, Jian-Ming;
- Hu, Xiu-Rong
Publication type:
Article
Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer.
Published in:
Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1136114
By:
- Tao Yuan;
- Ruilin Wu;
- Weihua Wang;
- Yue Liu;
- Wencheng Kong;
- Bo Yang;
- Qiaojun He;
- Hong Zhu
Publication type:
Article
Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study.
Published in:
Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.950101
By:
- Weihao Li;
- Xinyue Li;
- Kun Yu;
- Binyi Xiao;
- Jianhong Peng;
- Rongxin Zhang;
- Lingfang Zhang;
- Kun Wang;
- Zhizhong Pan;
- Cong Li;
- Xiaojun Wu
Publication type:
Article
A high throughput method for Monitoring of Sorafenib, regorafenib, cabozantinib and their metabolites with UPLC-MS/MS in rat plasma.
Published in:
Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.955263
By:
- Er-Min Gu;
- Ya-Nan Liu;
- Lvjun Pan;
- Yingying Hu;
- Xuemei Ye;
- Pingping Luo
Publication type:
Article
Inhibition of the PINK1-Parkin Pathway Enhances the Lethality of Sorafenib and Regorafenib in Hepatocellular Carcinoma.
Published in:
Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.851832
By:
- Zhang, Shun;
- Wang, Yixin;
- Cao, Yifan;
- Wu, Jin;
- Zhang, Zubin;
- Ren, Haigang;
- Xu, Xiaohui;
- Kaznacheyeva, Elena;
- Li, Qing;
- Wang, Guanghui
Publication type:
Article
Physiologically Based Pharmacokinetic Modelling to Predict Imatinib Exposures in Cancer Patients with Renal Dysfunction: A Case Study.
Published in:
Pharmaceutics, 2023, v. 15, n. 7, p. 1922, doi. 10.3390/pharmaceutics15071922
By:
- Rowland Yeo, Karen;
- Hatley, Oliver;
- Small, Ben G.;
- Johnson, Trevor N.
Publication type:
Article
Effect of Synchronous Versus Sequential Regimens on the Pharmacokinetics and Biodistribution of Regorafenib with Irradiation.
Published in:
Pharmaceutics, 2021, v. 13, n. 3, p. 386, doi. 10.3390/pharmaceutics13030386
By:
- Tsai, Tung-Hu;
- Chen, Yu-Jen;
- Wang, Li-Ying;
- Hsieh, Chen-Hsi;
- Wasan, Kishor
Publication type:
Article
Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure.
Published in:
Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 416, doi. 10.3390/ph13110416
By:
- Dolat, Marine;
- Macaire, Pauline;
- Goirand, Françoise;
- Vincent, Julie;
- Hennequin, Audrey;
- Palmier, Rémi;
- Bengrine-Lefevre, Leïla;
- Ghiringhelli, François;
- Royer, Bernard;
- Schmitt, Antonin
Publication type:
Article
Establishment of Colorectal Cancer Organoids in Microfluidic-Based System.
Published in:
Micromachines, 2021, v. 12, n. 5, p. 497, doi. 10.3390/mi12050497
By:
- Pinho, Diana;
- Santos, Denis;
- Vila, Ana;
- Carvalho, Sandra;
- Lazar, Iulia M.
Publication type:
Article
Heterogeneous constitutional mismatch repair deficiency with MSH6 missense mutation clinically benefits from pembrolizumab and regorafenib combination therapy: a case report and literature review.
Published in:
Hereditary Cancer in Clinical Practice, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s13053-021-00165-2
By:
- Xie, Tong;
- Feng, Qin;
- Li, Zhongwu;
- Lu, Ming;
- Li, Jian;
- Lizaso, Analyn;
- Xiang, Jianxing;
- Zhang, Lu;
- Shen, Lin;
- Peng, Zhi
Publication type:
Article
Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01581-3
By:
- Fang, Wanxia;
- Che, Xiaofang;
- Li, Guohui;
- Wang, Anhui;
- Wang, Yizhe;
- Shi, Xiaonan;
- Hou, Kezuo;
- Zhang, Xiaojie;
- Qu, Xiujuan;
- Liu, Yunpeng
Publication type:
Article
Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1412-8
By:
- Liu, Ziyu;
- Lin, Yan;
- Zhang, Jinyan;
- Zhang, Yumei;
- Li, Yongqiang;
- Liu, Zhihui;
- Li, Qian;
- Luo, Ming;
- Liang, Rong;
- Ye, Jiazhou
Publication type:
Article
An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia.
Published in:
Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0532-x
By:
- Zhisheng Her;
- Kylie Su Mei Yong;
- Paramasivam, Kathirvel;
- Wei Sheng Tan, Wilson;
- Xue Ying Chan;
- Sue Yee Tan;
- Min Liu;
- Yong Fan;
- Yeh Ching Linn;
- Kam Man Hui;
- Surana, Uttam;
- Qingfeng Chen
Publication type:
Article
Receptor tyrosine kinase fusions act as a significant alternative driver of the serrated pathway in colorectal cancer development.
Published in:
Journal of Pathology, 2020, v. 251, n. 1, p. 74, doi. 10.1002/path.5418
By:
- Chan, Anthony W‐H;
- Pan, Yi;
- Tong, Joanna H‐M;
- Lung, Raymond W‐M;
- Kwan, Johnny S‐H;
- Chow, Chit;
- Tin, Edith K‐Y;
- Chung, Lau‐Ying;
- Li, Hui;
- Wong, Shela S‐Y;
- Chau, Shuk‐Ling;
- Chan, Yuk Yu;
- Mak, Tony W‐C;
- Ng, Simon Siu‐Man;
- To, Ka‐Fai
Publication type:
Article
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5840, doi. 10.3390/ijms24065840
By:
- Lavacchi, Daniele;
- Roviello, Giandomenico;
- Guidolin, Alessia;
- Romano, Silvia;
- Venturini, Jacopo;
- Caliman, Enrico;
- Vannini, Agnese;
- Giommoni, Elisa;
- Pellegrini, Elisa;
- Brugia, Marco;
- Pillozzi, Serena;
- Antonuzzo, Lorenzo
Publication type:
Article
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5518, doi. 10.3390/ijms24065518
By:
- Thomas, Quentin Dominique;
- Firmin, Nelly;
- Mbatchi, Litaty;
- Evrard, Alexandre;
- Quantin, Xavier;
- Leenhardt, Fanny
Publication type:
Article
Current Targeted Therapy for Metastatic Colorectal Cancer.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1702, doi. 10.3390/ijms24021702
By:
- Ohishi, Tomokazu;
- Kaneko, Mika K.;
- Yoshida, Yukihiro;
- Takashima, Atsuo;
- Kato, Yukinari;
- Kawada, Manabu
Publication type:
Article
Regorafenib and Ruthenium Complex Combination Inhibit Cancer Cell Growth by Targeting PI3K/AKT/ERK Signalling in Colorectal Cancer Cells.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 686, doi. 10.3390/ijms24010686
By:
- Sharma, Deepu;
- Rasool, Fayyaz;
- Bharti, Manjri;
- Vyas, Komal M.;
- Magani, Sri Krishna Jayadev
Publication type:
Article
FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7782, doi. 10.3390/ijms23147782
By:
- Wuputra, Kenly;
- Hsiao, Pi-Jung;
- Chang, Wen-Tsan;
- Wu, Po-Hsuan;
- Chen, Lin-Ann;
- Huang, Jian-Wei;
- Su, Wen-Lung;
- Yang, Ya-Han;
- Wu, Deng-Chyang;
- Yokoyama, Kazunari K.;
- Kuo, Kung-Kai
Publication type:
Article
Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 8, p. 4408, doi. 10.3390/ijms23084408
By:
- Bajbouj, Khuloud;
- Qaisar, Rizwan;
- Alshura, Mohammed A.;
- Ibrahim, Zeinab;
- Alebaji, Mohamad B.;
- Al Ani, Amenah W.;
- Janajrah, Hanadi M.;
- Bilalaga, Mariah M.;
- Omara, Abdelrahman I.;
- Abou Assaleh, Rebal S.;
- Saber-Ayad, Maha M.;
- Elmoselhi, Adel B.
Publication type:
Article
Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1667, doi. 10.3390/ijms23031667
By:
- Takuma, Kei;
- Fujihara, Shintaro;
- Fujita, Koji;
- Iwama, Hisakazu;
- Nakahara, Mai;
- Oura, Kyoko;
- Tadokoro, Tomoko;
- Mimura, Shima;
- Tani, Joji;
- Shi, Tingting;
- Morishita, Asahiro;
- Kobara, Hideki;
- Himoto, Takashi;
- Masaki, Tsutomu
Publication type:
Article
Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib.
Published in:
International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11770, doi. 10.3390/ijms222111770
By:
- Fondevila, Flavia;
- Méndez-Blanco, Carolina;
- Fernández-Palanca, Paula;
- Payo-Serafín, Tania;
- van Pelt, Jos;
- Verslype, Chris;
- González-Gallego, Javier;
- Mauriz, José L.
Publication type:
Article
Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension.
Published in:
International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1502, doi. 10.3390/ijms22031502
By:
- Veeroju, Swathi;
- Kojonazarov, Baktybek;
- Weiss, Astrid;
- Ghofrani, Hossein Ardeschir;
- Weissmann, Norbert;
- Grimminger, Friedrich;
- Seeger, Werner;
- Novoyatleva, Tatyana;
- Schermuly, Ralph Theo;
- Guignabert, Christophe
Publication type:
Article
PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer.
Published in:
International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6907, doi. 10.3390/ijms21186907
By:
- Raimondi, Lucrezia;
- Raimondi, Filippo Maria;
- Di Benedetto, Laura;
- Cimino, Giuseppe;
- Spinelli, Gian Paolo
Publication type:
Article
Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines.
Published in:
International Journal of Molecular Sciences, 2020, v. 21, n. 9, p. 3349, doi. 10.3390/ijms21093349
By:
- Sasaki, Reina;
- Kanda, Tatsuo;
- Fujisawa, Mariko;
- Matsumoto, Naoki;
- Masuzaki, Ryota;
- Ogawa, Masahiro;
- Matsuoka, Shunichi;
- Kuroda, Kazumichi;
- Moriyama, Mitsuhiko
Publication type:
Article
Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C.
Published in:
International Journal of Molecular Sciences, 2020, v. 21, n. 1, p. 63, doi. 10.3390/ijms21010063
By:
- Nemoto, Emika;
- Kojima, Shota;
- Sugiyama, Tetsuya;
- Jin, Denan;
- Takai, Shinji;
- Maeda, Michiko;
- Kohmoto, Ryohsuke;
- Ueki, Mari;
- Oku, Hidehiro;
- Ikeda, Tsunehiko
Publication type:
Article
Effective Sequential Combined Chemotherapy with Trifluridine/Tipiracil and Regorafenib in Human Colorectal Cancer Cells.
Published in:
International Journal of Molecular Sciences, 2018, v. 19, n. 10, p. 2915, doi. 10.3390/ijms19102915
By:
- Matsuoka, Kazuaki;
- Nakagawa, Fumio;
- Tanaka, Nozomu;
- Okabe, Hiroyuki;
- Matsuo, Kenichi;
- Takechi, Teiji
Publication type:
Article
Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
Published in:
International Journal of Molecular Sciences, 2018, v. 19, n. 3, p. 739, doi. 10.3390/ijms19030739
By:
- Nakano, Kenji;
- Takahashi, Shunji
Publication type:
Article
Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer.
Published in:
BMC Geriatrics, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12877-022-03637-9
By:
- Chen, Beibei;
- Zhao, Huichen;
- Huang, Jinxi;
- Lv, Huifang;
- Xu, Weifeng;
- Nie, Caiyun;
- Wang, Jianzheng;
- Zhao, Jing;
- He, Yunduan;
- Wang, Saiqi;
- Chen, Xiaobing
Publication type:
Article
Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer.
Published in:
BMC Geriatrics, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12877-022-03637-9
By:
- Chen, Beibei;
- Zhao, Huichen;
- Huang, Jinxi;
- Lv, Huifang;
- Xu, Weifeng;
- Nie, Caiyun;
- Wang, Jianzheng;
- Zhao, Jing;
- He, Yunduan;
- Wang, Saiqi;
- Chen, Xiaobing
Publication type:
Article
Long-term survival of a patient with microsatellite-stable refractory colorectal cancer with regorafenib and PD-1 inhibitor sintilimab: a case report and review of literature.
Published in:
2021
By:
- Zhang, Yong;
- Zhang, Fang;
- Zhao, Lingdi;
- Fu, Xiaomin;
- Shang, Yiman;
- Gao, Quanli
Publication type:
journal article
Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study.
Published in:
2021
By:
- Han, Yue;
- Cao, Guang;
- Sun, Bin;
- Wang, Jian;
- Yan, Dong;
- Xu, Haifeng;
- Shi, Qinsheng;
- Liu, Zechuan;
- Zhi, Weihua;
- Xu, Liang;
- Liu, Bojun;
- Zou, Yinghua
Publication type:
journal article
Expression of tumor pyruvate kinase M2 isoform in plasma and stool of patients with colorectal cancer or adenomatous polyps.
Published in:
2020
By:
- Rigi, Farideh;
- Jannatabad, Aliakbar;
- Izanloo, Azra;
- Roshanravan, Reza;
- Hashemian, Hamid Reza;
- Kerachian, Mohammad Amin
Publication type:
journal article

Found: 449